Results 211 to 220 of about 72,525 (258)
Some of the next articles are maybe not open access.
Epidemiology of Invasive Fungal Infection
International Journal of Antimicrobial Agents, 2008Invasive fungal infection is a growing cause of morbidity and mortality in immunosuppressed patients. Furthermore, the use of azole prophylaxis against Candida species has coincided with an increase in the incidence of invasive aspergillosis and infections by other filamentous fungi such as Mucorales. New risk factors and different timescales for onset
Antonio Rivero, J Torre-Cisneros
exaly +3 more sources
Glucocorticoids and Invasive Fungal Infections
Lancet, The, 2003Since the 1990s, opportunistic fungal infections have emerged as a substantial cause of morbidity and mortality in profoundly immunocompromised patients. Hypercortisolaemic patients, both those with endogenous Cushing's syndrome and, much more frequently, those receiving exogenous glucocorticoid therapy, are especially at risk of such infections.
Dimitrios Kontoyiannis +1 more
exaly +3 more sources
Immunodiagnosis of invasive fungal infection
Medical Mycology, 1992Overview Invasive fungal infections are an important cause of morbidity and mortality, particularly in immunocompromised patients. The prognosis of these infections is poor unless they are diagnosed and treated promptly. Clinically, there is usually nothing specific to indicate a fungal infection and diagnosis depends on a combination of ...
Buckley, H R +3 more
openaire +3 more sources
Pathogenesis of invasive fungal infections
Current Opinion in Infectious Diseases, 2013Invasive fungal infection (IFI) is increasingly being recognized as a significant cause of morbidity and mortality in immunosuppressed patients. This review focuses on the latest literature reports concerning the pathogenesis of IFI in this population.New virulence factors of Candida and Aspergillus have recently been identified.
Carolina, Garcia-Vidal +2 more
openaire +2 more sources

